A carregar...
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma
BACKGROUND: Despite the recent improvements in multimodal therapies for oesophageal squamous cell carcinoma (ESCC), the prognosis remains poor. The identification of suitable biomarkers for predicting the prognosis and chemo-sensitivity is required to develop targeted treatments and improve treatmen...
Na minha lista:
Publicado no: | Br J Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4931380/ https://ncbi.nlm.nih.gov/pubmed/27310703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.183 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|